News Media

With a vision to make affordable & quality medicines Aprazer healthcare will manufacture world class oral solid drugs at state of art WHO-GMP….

Launch Date: 30/06/2021 Aprazer Healthcare Launched PIRFEKAST (Pirfenidone) which is a medication indicated for the treatment of idiopathic pulmonary fibrosis (IPF)…..

Launch Date: 26/02/21 Aprazer Healthcare Launched SUTEKAST (Sunitinib) which is a medication indicated for the treatment of rare cancer of the stomach, bowel, or esophagus called gastrointestinal…..

Launch Date: 11/01/21 Aprazer Healthcare Launched XGRAF (Tacrolimus Capsules ) which is used for the prophylaxis of organ rejection in adults and paediatric patients receiving kidney….

Launch Date: 19/12/20 Aprazer Healthcare Launched MEROAXIS (Meropenem Inj) which is a medication indicated for the treatment of susceptible infections including….

Launch Date: 07/12/20 Aprazer Healthcare Launched HQKAST (Hydroxychloroquine), which is a medication indicated for the treatment of Malaria….

Launch Date: 31/10/20 Aprazer Healthcare Launched CAPEKAST (Capecitabine) which is a medication indicated for the treatment of patients….

Launch Date: 17/10/20 Aprazer Healthcare Launched Lenvakast (Lenvatinib) which is a medication indicated for the treatment of patients….

Launch Date: 29/09/2020 Aprazer Healthcare Launched Lenakast (Lenalidomide) which is a medication indicated for the treatment of Myelodysplastic Syndromes….

Launch Date: 31/08/20 Aprazer Healthcare Launched TAMIKAST (Oseltamivir) which is a medication indicated for the treatment of Influenza Infection and

Launch Date: 29/08/20 Aprazer Healthcare Launched INLYBEST (Axitinib) which is a medication indicated for the treatment of Advanced Renal Cell

Launch Date: 10/08/20 Aprazer Healthcare Launched OCABEST (Obeticholic Acid ) which is a medication indicated for the treatment of Primary